-
Dec 4, 2024 | 
outsourcedpharma.com | Louis Garguilo |William Powers |Jenny Minigh |inSeption Group
Whitepaper: Nose to Brain (N2B) Drug Delivery – Benefits and Challenges. The brain and central nervous system (CNS) are critical yet challenging targets for drug delivery due to barriers like the blood-brain barrier. Explore the benefits and challenges of Nose to Brain (N2B) delivery, including delivery targets, transport mechanisms, liquid and dry powder formulations, and the development of nasal dosage forms.
-
Dec 4, 2024 | 
clinicalleader.com | Dan Schell |Treating Deficiencies |Jenny Minigh |inSeption Group
Right-sized for biotech successIt's not the size of your company. It’s the size of your passion and your dedication to improving patients’ lives that IQVIA Biotech is uniquely built to serve. There is nothing bigger to us than your success. We've got you.
-
Sep 11, 2024 | 
outsourcedpharma.com | Louis Garguilo |Jenny Minigh |inSeption Group
Technical Excellence In ADC ManufacturingOn October 24, join industry experts for an exclusive series of cutting-edge presentations on demonstrating technical excellence in process development and manufacturing for ADCs and bioconjugates. Register to gain access to expert knowledge that will drive innovation and accelerate your ADC development and manufacturing program.
-
Jul 31, 2024 | 
clinicalleader.com | Dan Schell |Jenny Minigh |inSeption Group |Treating Deficiencies
Right-sized for biotech successIt’s not the size of your company. It’s the size of your passion and your dedication to improving patients’ lives that IQVIA Biotech is uniquely built to serve. There is nothing bigger to us than your success. We’ve got you.
-
Jun 14, 2024 | 
outsourcedpharma.com | Louis Garguilo |Anthony Qu |Jenny Minigh
With over 35 years’ experience in the medtech, diagnostics, and pharmaceutical markets, SMC Ltd. provides in-house engineering, injection molding, assembly, fill finish, device manufacturing, packaging services, and can manage sterilization. Our customers rely on us for speed-to-market and our program management process is a key to well managed projects. With inhouse global supply chain expertise, we help customers reduce risk while maintaining tight timeframes.
-
May 30, 2024 | 
pharmaceuticalonline.com | Saddam Nawaz |Jenny Minigh |inSeption Group
Webinar: Dry Powder Inhalable Vaccines for Shelf Stability and Global AccessThere is a significant need for shelf-stable vaccines that are simpler to store and distribute. Vaccines require cold chain distribution and to be stored in a refrigerator or freezer. This webinar will look at the formulation of vaccines with dry powder respiratory delivery in mind, and manufacturing considerations for dry powder inhaled vaccines. Click here to learn more.
-
May 3, 2024 | 
cellandgene.com | Jenny Minigh |inSeption Group
By Jenny Minigh, inSeption Group
Ask most companies, “how is your mentoring?” and, in their minds, they have effective training and mentoring support. And it looks like this: every year, employees complete goal-setting with management and, at the end of the year, they are graded on whether they met those goals. Success might mean a bonus, a raise, and/or a promotion.
But managerial support of strategic advancement up the career ladder is NOT the mentorship most people crave and need.
-
Apr 11, 2024 | 
outsourcedpharma.com | Louis Garguilo |Antony Hitchcock |AGH Bioconsulting |Jenny Minigh
Webinar: De-Risking The Aseptic Drug-Filling Process And Optimizing ProductionIn the aseptic drug-filling process for biotherapeutics, your company may find it challenging to meet regulatory compliance standards, putting the safety and effectiveness of your products at risk. Join us and gain valuable insights into enhancing the efficiency and reliability of the drug product manufacturing process.
-
Mar 1, 2024 | 
cellandgene.com | Jenny Minigh |inSeption Group
Article
| March 1, 2024
By Jenny Minigh, inSeption Group
A quick review of the presentation agenda at the 2023 American Medical Writers Association annual conference left no doubt: medical writers want to know more about the use of artificial intelligence (AI) in the pharmaceutical industry and its effect on their future employment. The conference welcomed multiple vendors offering promising AI solutions to fulfill medical writing needs.
-
Feb 23, 2024 | 
outsourcedpharma.com | Tim Sandle |Jenny Minigh |inSeption Group |Louis Garguilo
To improve the quality of abbreviated new drug applications (ANDAs) and to ensure improved consistency, the FDA has developed a new guidance to assist applicants in preparing and submitting amendments to tentatively approved ANDAs or in seeking final approval. This new guidance replaces the previous September 2020 version.
